GlassScriptPhysician profile
Pariksith Singh
NPI 1417989625
$3,765.42
in general payments reported to CMS, 2019-2025
9 companies · $73.36 in 2025
The $73.36 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2021: $113 · 2022: $13.50 · 2023: $19.49 · 2024: $3,408 · 2025: $73.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $3,408 · Food and Beverage: $92.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $3,408.34 |
| Food and Beverage | $92.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $3,408.34 | 2024 | Evis Exera III Colonovideoscope |
| Pfizer INC. | $147.36 | 2019-2025 | |
| Astellas Pharma US INC | $85.00 | 2021 | |
| Insmed, INC. | $29.67 | 2025 | Arikayce |
| Amgen INC. | $27.78 | 2021 | |
| Si-Bone, INC. | $24.59 | 2025 | |
| Glaxosmithkline, LLC. | $15.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.65 | 2019 | |
| Abbvie INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pariksith Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.